510(k) Report

510(k) · Cleared

Cleared

GSI Novus

K172403510(k) TraditionalCleared Oct 20, 201772-day reviewClass II21 CFR 874.1050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Grason-Stadler, Inc. · EWO Audiometer

Cleared on Oct 20, 2017 as substantially equivalent to K103760 (Interacoustics A/S, 2011) and 1 other predicate after a 72-day review. Its family tree reaches back 3 generations to 2006.

Decided
Oct 20, 2017
Review
72 days
Class
Class II
Product code
EWO
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to K060539 (2006). 5 ancestors in all, the oldest K052562 (2005). No later device cites it as a predicate yet.

Other ancestors, by year cleared 2009: 1 other ancestor2005: 1 other ancestorK060539 · DPOAE20 , Eclipse · Interacoustics A/S, Assens · 2006K103760 · TITAN · Interacoustics A/S · 2011K130795 · TITAN · Interacoustics A/S · 20132006200820102012201420162018
Other ancestors, by generation 2 generations back: 2 other ancestors K130795 · TITAN · Interacoustics A/S · 2013K103760 · TITAN · Interacoustics A/S · 2011K060539 · DPOAE20 , Eclipse · Interacoustics A/S, Assens · 20060
  1. Root · 3 generations backK060539 DPOAE20 , EclipseInteracoustics A/S, Assens · 2006
  2. 2 generations backK103760 TITANInteracoustics A/S · 2011
  3. 1 generation backK130795 TITANInteracoustics A/S · 2013
  4. This deviceK172403 GSI NovusGrason-Stadler, Inc. · 2017
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K060539DPOAE20 , EclipseInteracoustics A/S, Assens2006—
−2K103760TITANInteracoustics A/S2011—
−1K130795TITANInteracoustics A/S2013—
0 (this device)K172403GSI NovusGrason-Stadler, Inc.2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200510
200910
FIG. 1 — Lineage of K172403, 2006–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in EWO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new EWO device

  1. #1 K234095 OtoNova/OtoNova Proscore 9.3 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K103760TITAN
Summary page 4
…Throat / Neurology Classification Regulation: 874.1050/882.1900 Product Code: EWO/GWJ Predicate Device 1: Titan (with DPOAE440 and ABRIS440), cleared on 05/05/2011 via K103760 Predicate Device 2: Titan (with TEOAE440), cleared on 06/20/2013 via K130795 Device Description The device is audiometric equip…
Interacoustics A/S2011—
*K130795TITAN
Summary page 4
…: EWO/GWJ Predicate Device 1: Titan (with DPOAE440 and ABRIS440), cleared on 05/05/2011 via K103760 Predicate Device 2: Titan (with TEOAE440), cleared on 06/20/2013 via K130795 Device Description The device is audiometric equipment used for testing of inner ear and auditory brainstem abnormalities. Nov…
Interacoustics A/S2013—

Also cleared against K103760: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 11 years and passes through 3 companies; a new generation was cleared every 4.3 years on median.
  • None of the 5 ancestors has a recall.
  • 3 other devices also cite its predicate K103760.

How does its category compare?

All EWO devices

EWO Audiometer: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · EWO

2in 2024

2007: 52008: 12009: 22010: 22011: 32012: 42013: 22014: 12015: 42017: 22018: 22019: 12022: 12023: 12024: 2
2007high 5 (2007) · low 0 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · EWO

173in 2015

2007: 69 days median2011: 151 days median2012: 137 days median2015: 173 days median
2007high 173 (2015) · low 69 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · EWO

4in 2023

2008: 12023: 4
2007high 4 (2023) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · EWO

13in 2025

2007: 12008: 12009: 12010: 42011: 22015: 12019: 62020: 72021: 32022: 62023: 32024: 22025: 13
2007high 13 (2025) · low 0 (2012)2025

MAUDE reports naming product code EWO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200756901
20081—11
20092—01
20102—04
2011315102
2012413700
20132—00
20141—00
2015417301
20160—00
20172—00
20182—00
20191—06
20200—07
20210—03
20221—06
20231—43
20242—02
20250—013
20260—0—

What is it indicated for?

The GSI Novus is intended to be used for the measurement and automated analysis of auditory evoked responses (auditory brainstem responses, ABR) and/or otoacoustic emissions (distortion product, DPOAE and transient evoked, TEOAE). These measures are useful in the screening evaluation, identification, documentation and diagnosis of auditory and hearing related disorders. The auditory evoked response (ABR) measurement is intended for newborns and infants…

Read the full statement (135 words)

The GSI Novus is intended to be used for the measurement and automated analysis of auditory evoked responses (auditory brainstem responses, ABR) and/or otoacoustic emissions (distortion product, DPOAE and transient evoked, TEOAE). These measures are useful in the screening evaluation, identification, documentation and diagnosis of auditory and hearing related disorders. The auditory evoked response (ABR) measurement is intended for newborns and infants up to 6 months of age. The otoacoustic emissions (DPOAE and/or TEOAE) measurement is intended for use in patients of all ages.

The GSI Novus is intended to be used by a healthcare professional such as an ENT doctor, nurse or audiologist or by a trained technician under the supervision of a professional. The device is intended to be used in a hospital, clinic, or other facility with a suitable quiet testing environment.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K172403: GSI Novus.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K172403

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026